THU277 Deletion Or inhibition Of Ornithine Decarboxylase Protects Islet β-cell Health And Is Associated With Preserved Residual C-peptide In Persons With Recent Onset Type 1 Diabetes
Batoul Hammoud(Children's Hospital of Philadelphia), Emily K. Sims(University School), Stéphanie Woerner(Délégation Paris 7), Bobbie‐Jo Webb‐Robertson(Pacific Northwest National Laboratory), Susanne M. Cabrera(Medical College of Wisconsin), Raghavendra G. Mirmira(University of Chicago), Ernesto Nakayasu(Pacific Northwest National Laboratory), Linda A. DiMeglio(Urology of Indiana), Lucy D. Mastrandrea(University at Buffalo, State University of New York), Carmella Evans‐Molina(Richard L. Roudebush VA Medical Center), Teresa L. Mastracci(Indiana University Indianapolis), Soumyaddep Sarkar(Pacific Northwest National Laboratory), Fangian Ouyang(Indiana University – Purdue University Indianapolis), Sarah A. Tersey(Diabetes Australia), Eugene W. Gerner(University of North Carolina at Chapel Hill), Audrey Hull(Nationwide Children's Hospital), Abishek Kulkarni(University of Chicago), Susan N. Perkins(Frederick National Laboratory for Cancer Research)
Cited by 0
Related Papers
Restructuring of the Gut Microbiome by Intermittent Fasting Prevents Retinopathy and Prolongs Survival in <i>db/db</i> Mice
|Diabetes|2018|385
Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes
|Diabetes Care|2019|350
ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption
|Journal of Clinical Investigation|2013|341
Review, Evaluation, and Discussion of the Challenges of Missing Value Imputation for Mass Spectrometry-Based Label-Free Global Proteomics
|Journal of Proteome Research|2015|318
The Cancer Microbiome: Distinguishing Direct and Indirect Effects Requires a Systemic View
|Trends in cancer|2020|266